// App-Quantinova.ai

: Efficacy and Safety of Prothrombin Complex Concentrate (PCC) for Direct Oral Anticoagulant Reversal: A Single Institutional Experience

Researchers

Presenter

  • Meera Sridharan

Principal Investigators

  • Narith N Ou

  • Lance J. Oyen

  • Aneel A. Ashrani

  • Robert D. McBane

  • Rajiv K. Pruthi

Medical Centers

  • Mayo Clinic, Rochester, MN

  • Mayo Clinic, Rochester, MN

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Collagen type IV alpha 2 chain

  • Prothrombin

Drug/Treatment

  • Prothrombin complex

  • rivaroxaban

  • Hemostatic Solution

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved